Brief: Guerbet Announces Marketing Authorisation Approval Of Elucirem™ (Gadopiclenol) In The European Union
Guerbet SA GRBT.PA :
* GUERBET ANNOUNCES MARKETING AUTHORISATION APPROVAL OF
ELUCIREM™
(GADOPICLENOL) IN THE EUROPEAN UNION
Source text for Eikon: ID:nPrez1Dpja
Further company coverage: GRBT.PA
Recent news on Guerbet SA
See all newsBrief: Guerbet Revenue At 30 September 2026 Of EUR 573.8 Million
Corrected: French medical imaging firm Guerbet's 9M revenue slips on China sales drop
French medical imaging firm Guerbet H1 EBITDA margin falls on Raleigh site costs
Brief: Guerbet H1 EBITDA €30.6 Mln
French and Benelux stocks-Factors to watch